Daewoong Pharmaceutical Revenue

Daewoong Pharmaceutical had revenue of 358.47B KRW in the quarter ending September 30, 2024, with 5.16% growth. This brings the company's revenue in the last twelve months to 1.42T, up 5.62% year-over-year. In the year 2023, Daewoong Pharmaceutical had annual revenue of 1.38T with 7.44% growth.

Revenue (ttm)

1,416.63B

Revenue Growth

+5.62%

P/S Ratio

1.14

Revenue / Employee

820.28M

Employees

1,727

Market Cap

1,610.88B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1,375.33B	95.24B	7.44%
Dec 31, 2022	1,280.09B	127.12B	11.03%
Dec 31, 2021	1,152.98B	97.55B	9.24%
Dec 31, 2020	1,055.42B	-58.00B	-5.21%
Dec 31, 2019	1,113.43B	82.00B	7.95%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,364.39B
Celltrion	2,876.25B
Yuhan	2,008.84B
SK Biopharmaceuticals	511.33B
SK bioscience	201.30B
Hanmi Pharm.	1,566.25B
Hanall Biopharma	134.24B
Hanmi Science	1,283.65B

Revenue Rankings